FORTRESS BIOTECH INC - FBIO 9 3/8 PERP (FBIOP) Stock Cash Flow
NASDAQ:FBIOP - Nasdaq - US34960Q2084 - Currency: USD
| TTM (2025-3-31) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -106.52M | -120.86M | -154.15M | -213.91M | -164.83M | |||
| Depreciation Amortization | 4.46M | 4.46M | 6.00M | 7.39M | 5.10M | |||
| Income Taxes - Deferred | N/A | N/A | N/A | N/A | N/A | |||
| Change In Working Capital | -16.77M | -8.13M | -12.52M | -720.00K | 36.37M | |||
| Interest Paid | 8.82M | 7.16M | 7.95M | 9.42M | 6.92M | |||
| Taxes Paid | N/A | 120.00K | -55.00K | 860.00K | 990.00K | |||
| Other non cash items | 44.46M | 44.33M | 32.45M | 27.84M | 6.81M | |||
| OPERATING CASH FLOW | -74.37M | -80.19M | -128.22M | -179.40M | -116.54M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | N/A | -15.00M | -5.06M | -2.72M | -4.97M | |||
| Other Investing Activity | 1.17M | 0.00 | 2.96M | -20.21M | 45.48M | |||
| INVESTING CASH FLOW | -13.84M | -15.00M | -2.10M | -22.93M | 40.51M | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | -9.21M | -8.58M | -39.79M | 44.25M | -6.19M | |||
| Stock Issued/Repurchased | 89.31M | 71.64M | 76.71M | 25.70M | 44.73M | |||
| Dividend Paid | -2.69M | -4.71M | -8.77M | -8.78M | -8.78M | |||
| Other Financing Activity | 17.52M | 12.29M | 4.59M | 14.16M | 119.23M | |||
| FINANCING CASH FLOW | 94.92M | 70.64M | 32.74M | 75.32M | 148.99M | |||
| CHANGE IN CASH | 6.72M | -24.55M | -97.59M | -127.01M | 72.96M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -74.37M | -80.19M | -128.22M | -179.40M | -116.54M | |||
| Capital Expenditure | N/A | -15.00M | -5.06M | -2.72M | -4.97M | |||
| FREE CASH FLOW | -89.37M | -95.19M | -133.29M | -182.12M | -121.51M | |||
All data in USD